Fate Therapeutics Statistics
Total Valuation
FATE has a market cap or net worth of $486.06 million. The enterprise value is $189.41 million.
| Market Cap | 486.06M |
| Enterprise Value | 189.41M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FATE has 113.83 million shares outstanding. The number of shares has increased by 3.11% in one year.
| Shares Outstanding | 113.83M |
| Shares Change (YoY) | +3.11% |
| Shares Change (QoQ) | +2.52% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 109.57% |
| Float | 90.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 75.03 |
| Forward PS | 116.04 |
| PB Ratio | 1.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 29.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.69, with a Debt / Equity ratio of 0.24.
| Current Ratio | 8.69 |
| Quick Ratio | 8.81 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.50% and return on invested capital (ROIC) is -40.32%.
| Return on Equity (ROE) | -46.50% |
| Return on Assets (ROA) | -34.50% |
| Return on Capital (ROIC) | -40.32% |
| Revenue Per Employee | $35,790 |
| Profits Per Employee | -$1.05M |
| Employee Count | 181 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.17% in the last 52 weeks. The beta is 1.90, so FATE's price volatility has been higher than the market average.
| Beta (5Y) | 1.90 |
| 52-Week Price Change | -7.17% |
| 50-Day Moving Average | 3.69 |
| 200-Day Moving Average | 4.25 |
| Relative Strength Index (RSI) | 64.09 |
| Average Volume (20 Days) | 2,280,801 |
Short Selling Information
The latest short interest is 19.87 million, so 17.46% of the outstanding shares have been sold short.
| Short Interest | 19.87M |
| Short Previous Month | 21.15M |
| Short % of Shares Out | 17.46% |
| Short % of Float | 21.96% |
| Short Ratio (days to cover) | 8.56 |
Income Statement
In the last 12 months, FATE had revenue of $6.48 million and -$190.05 million in losses. Loss per share was -$1.92.
| Revenue | 6.48M |
| Gross Profit | 6.48M |
| Operating Income | -212.99M |
| Pretax Income | -190.05M |
| Net Income | -190.05M |
| EBITDA | -171.14M |
| EBIT | -190.05M |
| Loss Per Share | -$1.92 |
Balance Sheet
The company has $398.72 million in cash and $102.07 million in debt, giving a net cash position of $296.65 million or $2.61 per share.
| Cash & Cash Equivalents | 398.72M |
| Total Debt | 102.07M |
| Net Cash | 296.65M |
| Net Cash Per Share | $2.61 |
| Equity (Book Value) | 426.12M |
| Book Value Per Share | 3.74 |
| Working Capital | 349.01M |
Cash Flow
In the last 12 months, operating cash flow was -$136.75 million and capital expenditures -$3.03 million, giving a free cash flow of -$139.78 million.
| Operating Cash Flow | -136.75M |
| Capital Expenditures | -3.03M |
| Free Cash Flow | -139.78M |
| FCF Per Share | -$1.38 |
Margins
Gross margin is 100.00%, with operating and profit margins of -3,287.85% and -2,933.79%.
| Gross Margin | 100.00% |
| Operating Margin | -3,287.85% |
| Pretax Margin | -2,933.79% |
| Profit Margin | -2,933.79% |
| EBITDA Margin | -2,641.85% |
| EBIT Margin | -2,933.79% |
| FCF Margin | -2,157.83% |
Dividends & Yields
FATE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.11% |
| Shareholder Yield | -3.11% |
| Earnings Yield | -39.10% |
| FCF Yield | -28.76% |
Analyst Forecast
The average price target for FATE is $6.85, which is 60.42% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.85 |
| Price Target Difference | 60.42% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 7.20% |
| EPS Growth Forecast (5Y) | -10.96% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FATE has an Altman Z-Score of -1.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.42 |
| Piotroski F-Score | 2 |